All News #Library
Biotech
CellCentric Starts Pivotal Phase 2 DOMMINO-1 Trial of Inobrodib
31 Mar 2026 //
BUSINESSWIRE
Pfizer-backed CellCentric secures $120M for ph. 3 myeloma trial
20 May 2025 //
FIERCE BIOTECH
British biotech CellCentric expands to Boston, plans hiring push
02 Apr 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support